洞察瘤微环境中的IL-6/JAK/STAT3信号传递:对癌症治疗的影响
Win Lwin Thuya1, Yang Cao2, Paul Chi-Lui Ho3
1Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
Cytokine & growth factor reviews
|February 1, 2025
概括
IL-6/JAK/STAT3通路为癌症生长和免疫逃避提供燃料. 抑制这种途径有望克服治疗阻力并改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 介素-6 (IL-6) / Janus Kinase (JAK) /信号转换器和转录3激活器 (STAT3) 信号通路对于癌症的进展,免疫逃避和治疗耐药性至关重要.
- 这种途径的失调促进了瘤细胞的增殖,生存,血管新生,转移,并创造了一个免疫抑制性瘤微环境 (TME).
研究的目的:
- 审查IL-6/JAK/STAT3通路在癌症中的多方面的作用.
- 探索针对这种途径的治疗策略及其在个性化医学中的潜力.
主要方法:
- 关于癌症IL-6/JAK/STAT3信号传导的临床前和临床研究的文献综述.
- 分析治疗方法,包括单克隆抗体,JAK抑制剂和STAT3抑制剂.
主要成果:
- IL-6/JAK/STAT3通路通过招募TAMs,CAFs和Tregs等细胞来驱动瘤发生和免疫抑制.
- 用抑制剂准这个轴可以减少瘤生长,逆转免疫抑制,并提高免疫疗法的疗效.
- 组合疗法和先进的策略,如基于RNA的疗法,可以改善患者的治疗结果.
结论:
- IL-6/JAK/STAT3通路是癌症进展和治疗耐药性的重要驱动因素.
- 针对这种途径对开发有效的癌症治疗有很大的希望,特别是在组合疗法中.
- 由生物标志物指导的个性化医疗方法将是优化针对IL-6/JAK/STAT3轴的干预措施的关键.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.3K
07:12Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
3.5K
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
